Phase 1two3 is a consulting firm to the biopharmaceutical industry. Phase 1two3 partners have expertise in drug development from discovery research through Phase III development, as well as business and corporate development. In addition, Phase 1two3 owns a portfolio of intellectual property in the field of oncology.

Phase 1two3 provides hands-on assistance with corporate planning and execution on multiple levels. This includes tasks from annual strategic planning to the more tactical details of executing a business plan or designing a clinical trial.